Ahhhh Jeeezz I forgot something that is relevant.
All those production figures and profit figures were in US dollars but the EXT share price is in Aus dollars.
So the key variables must be:
*The cost of production per pound
*The Contract price
*The JV split with Rio
*The annual production in millions of pounds
*The number of EXT shares on issue
*The expected price/earnings ratio the market will apply
*EXCHANGE RATE US/AUS dollar
So going back to the figures:
Earnings would have been 8 x 70 = US$560 million
at an exchange rate of (say) 0.70 (is that fair?) this equates to Aus$800 million pa
At 50/50 that means 400/222 eps = 1.8
For the scenario I have painted here the price/earnings ratio (at current price of $4.30) would be 4.30/1.8 = 2.38
If the fair p/e ratio was 10 then that means a share price of Aus$18
My apologies for that confusion.
If the Aus dollar goes way higher then obviously we will earn less, if Aus dollar goes down that is more money for us.
- Forums
- ASX - By Stock
- rio will seek to negotiate a joint venture
Ahhhh Jeeezz I forgot something that is relevant.All those...
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EXT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.08M |
Open | High | Low | Value | Volume |
0.9¢ | 1.0¢ | 0.9¢ | $52.96K | 5.716M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 708194 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 7745064 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 708194 | 0.009 |
10 | 6523057 | 0.008 |
10 | 4306019 | 0.007 |
5 | 1618942 | 0.006 |
3 | 5500000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 7745064 | 14 |
0.011 | 5248150 | 6 |
0.012 | 5938361 | 5 |
0.013 | 10099423 | 3 |
0.014 | 15131428 | 3 |
Last trade - 15.57pm 15/07/2024 (20 minute delay) ? |
Featured News
EXT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online